Position in TNYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,311
-$4,814 QoQ
Shares Held
20,719
-28.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 101 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TNYA ranks #333 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TNYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,311 | 20,719 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $20,125 | 29,083 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $22,837 | 32,075 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $68,036 | 41,998 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $32,293 | 52,855 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $53,404 | 93,694 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $210,864 | 147,458 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $305,742 | 158,416 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $389,626 | 125,686 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,181,293 | 225,869 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $482,114 | 148,801 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $168,083 | 65,915 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $254,664 | 43,384 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $199,807 | 70,108 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $156,891 | 78,056 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $74,231 | 25,597 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,402 | 17,656 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $215,632 | 18,305 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $279,304 | 14,739 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $21,371 | 1,035 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||